We’re excited to present the opportunity to invest in ShapeScale’s $1M round. ShapeScale is revolutionizing health and fitness with its 3D body scanning technology, providing actionable, data-driven insights for both businesses and consumers.

• Traction: $900K ARR with 30% month-over-month growth over 15 months. Revenues grew 3000% YoY to $1M+ in 2024.

• Market Potential: Capturing just 10% of Peloton or Oura’s 5M users will yield a $100M+ ARR business.

• Strong Engagement: We are reaching 12,000 users. Customers love it, use it consistently, and businesses pay for it.

• Backed by Leaders: Supported by Y Combinator, StartX, Alsop Louie Partners, and more.

ShapeScale is raising $1M to scale from $1M ARR to $3M ARR. Join us in transforming health and fitness with a proven product and market demand.

The Problem

For the past 50 years, people have relied on traditional weight scales—and they simply don’t work!

• We don't know how our body and body shape change over time.
• When you gain or lose pounds, you can't tell where.
• The issue has grown into a societal challenge: 70% of the U.S. population is now overweight or obese.

The Solution

A body scanner that shows you where you lose the pounds and what they are made of!

ShapeScale create a 3D photorealistic digital record of your body and provides insight on where and how your body has been changing over time.

It combines the functions of a DEXA scan, before-and-after photos, tape and volume measurements and weight scale all in a one-minute scan.

Here is a video of ShapeScale in action:

Why Now?

Something fascinating is unfolding: weight loss treatments are experiencing explosive growth, reshaping the fitness, medical spa, weight loss clinic, and plastic surgery markets. Currently, 80% of these businesses now offer medicated weight loss programs—even Equinox has joined the trend. With oral versions of these medications expected to launch in 2026, this movement is poised to reach an even broader audience. Weight loss now sits at the crossroads of aesthetics, fitness, and health—precisely where ShapeScale excels.

Growth

GLP-1 treatments have opened the door to a thriving market for us. In just one year, we’ve grown from a few pilot locations to over 375 medical spas, gyms, and weight loss clinics across the U.S. Ultimately, everyone will have a ShapeScale in their home. For now, businesses are paying us to build our consumer base! In fact, we are already reaching over 12,000 users.

After doing pilots in 2023 and reaching $48K ARR we have been growing at over 30% MoM during the last 14 months up to $900K ARR (blended).

On the consumer side we have 4,750 pre-orders for ShapeScale and its subscription, not only validating our revenue model but also showing that there is significant demand for the such product.

2024 Results:

We have reached $1M+ in revenues in 2024 and achieved 30x YoY growth.

Revenue Model

For Businesses:

The majority of our business customers opt for a subscription model, paying $199 per month with annual billing or $299 per month with monthly billing. Approximately 10% of them purchase ShapeScale outright for $9,780.

For Consumers:

We sell ShapeScale at home with an attached subscription. It's $999 for the device and $9.99/month for the subscription. With financing the price is $39 / month, less than the price of one personal training session and a third of what you would pay for a Tonal or a Peloton.

Product Market Fit

At Businesses:x

Check this YouTube playlist for more testimonials

At Home:

We are confident that ShapeScale will be a success in the home. We’ve already shipped units to hundreds of early adopters, and once people begin scanning, they continue to engage. Our NPS with early home users (over 70) rivals industry leaders like Apple (72) and Netflix (67).

Unit of economics

Our unit economics are built for scale and profitability. On the B2B side, we’re achieving a 16:1 LTV-to-CAC ratio with a $16K lifetime value and just $1K customer acquisition cost. On the B2C side, we’re seeing an even stronger 18:1 ratio, with $1,800 LTV and only $100 CAC. With churn below 15% annually, our metrics are not just solid—they’re Series B-ready. This is a business model primed for rapid growth and long-term profitability.

The big opportunity

Peloton (or Oura) have sold over 5 million units. If we capture just 10% of their users, that’s 500,000 ShapeScale customers—enough to generate over $100M in ARR. And the best part? We believe our consumer market extends far beyond that, with massive untapped potential.

Team

Our team is the engine behind ShapeScale’s success, bringing together deep expertise in engineering, marketing, and operations. With a track record of launching dozens of products at startups and driving millions in revenue, we have the experience needed to execute and scale. Our team members have honed their skills at industry leaders like Schneider Electric, SpotOn, Phonejoy, Geosatis, to name a few, equipping us with the knowledge and proven ability to bring ShapeScale to market and achieve sustainable growth.

Vision

One day, every home will have a body scanner. You’ll just walk in front of it and it will reveal how your body has changed, offering personalized recommendations to help you live healthier, enhance your appearance, and increase your lifespan. Over time, it could even detect up to 80% of diseases earlier than is possible today, paving the way for a new era of preventive healthcare—all from the comfort of your home.

Why Invest?

ShapeScale is the future of personalized health and fitness. As the demand for cutting-edge, data-driven tools to improve health and aesthetics continues to grow, we are leading the charge in transforming how people understand and enhance their bodies. Backed by top investors including Y Combinator, StartX, Alsop Louie Partners, Rebel Fund, and Alumni Ventures, we’ve experienced remarkable growth, generating $900K in ARR and achieving over 30% month-over-month growth over the past 14 months, cementing our position as a leader in body imaging technology.

The Ask

We’ve spent the last year de-risking the business: the product works, people love it, it generates value for businesses that pay for it, and consumers are asking for it in their homes. When we sell it to them, they start scanning—and they don’t stop. All we need now is capital to grow. We are raising $1M to scale from $1M ARR to $3M ARR, with half of this amount already committed by key opinion leaders and doctors who believe in the product.

Additional information:

Medical Advisors

We’re honored to have renowned experts on our Medical Advisory Board, including:

• Dr. Renato Saltz: A globally recognized plastic surgeon based in Salt Lake City and a former president of ASAPS and ISAPS. Dr. Saltz’s pioneering work in body contouring and comprehensive aesthetic care makes him an invaluable guide as ShapeScale evolves.

• Dr. Johnny Franco: A board-certified plastic surgeon and thought leader in Austin, Texas, specializing in body contouring and facial aesthetics. Dr. Franco’s expertise in cosmetic surgery and weight loss practices provides invaluable insights into ShapeScale’s applications in both aesthetics and health.

• Dr. Daniel Gould: A distinguished plastic surgeon from Beverly Hills known for advanced reconstructive and cosmetic procedures. Dr. Gould’s innovative techniques and dedication to enhancing natural beauty align perfectly with ShapeScale’s mission.

• Terri Ross: An internationally acclaimed consultant in the aesthetics and medical spa industry. With over 20 years of experience, Terri brings unparalleled expertise in operational excellence, patient experience, and strategic growth, ensuring ShapeScale scales effectively to meet the demands of the medical and aesthetic markets.

Tech

We’re developing a revolutionary computer vision-driven body scanning solution to achieve three key objectives:

1. Effortless Scanning: Simplify the process so users can be captured seamlessly “on the fly.”

2. Health Insights: Build a medical dataset linking 3D scans with anatomical data for actionable insights.

3. Deeper Understanding: Learn the 3D structure and semantics of the human body.

Powered by non-rigid body reconstruction, anatomical data correlation, and 4D multi-spectral capture, this technology enables at-home health tracking and earlier detection of diseases.

We hold three granted patents that protect our scanning technology and underlying innovations.

Our initial work with medical datasets has demonstrated that we outperform current market leaders. For instance, using our dataset of 1,000 DEXA scans, we can estimate body composition with exceptional accuracy.

Manufacturing

We have built a 10,000 sq ft manufacturing, assembly and testing facility with our manufacturing partner. It has the capacity of producing up to 40,000 units per year.

The impact of our Wefunder

Looking at the side-by-side comparison of our original prototype and the current ShapeScale, the progress is clear. What started as a bold idea is now a reality—thanks to our incredible Wefunder investors.

Your early belief and support made it possible to turn sketches and rough concepts into a sophisticated product that’s changing lives. You laid the foundation for everything we’ve achieved, and we couldn’t have done it without you.

Thank you for your trust, support, and for being a vital part of our journey.